Gene medicine : A new field of molecular medicine

被引:18
作者
Kim, CK [1 ]
Haider, KH [1 ]
Lim, SJ [1 ]
机构
[1] Seoul Natl Univ, Coll Pharm, Natl Res Lab Drug & Gene Delivery, Kwanak Gu, Seoul 151742, South Korea
关键词
gene therapy; delivery system; viral; non-viral;
D O I
10.1007/BF02976486
中图分类号
R914 [药物化学];
学科分类号
100701 [药物化学];
摘要
Gene therapy has emerged as a new concept of therapeutic strategies to treat diseases which do not respond to the conventional therapies. The principle of gene therapy is to introduce genetic materials into patient cells to produce therapeutic proteins in these cells. Gene therapy is now at the stage where a number of clinical trials have been carried out to patients with gene-deficiency disease or cancer. Genetic materials for gene therapy are generally composed of gene expression system and gene delivery system. For the clinical application of gene therapy in a way which conventional drugs are used, researches have been focused on the design of gene delivery system which can offer high transfection efficiency with minimal toxicity. Currently, viral delivery systems generally provide higher transfection efficiency compared with non-viral delivery systems while non-viral delivery systems are less toxic, less immunogenic and manufacturable in large scale compared with viral systems. Recently, novel strategies towards the design of new non-viral delivery system, combination of viral and non-viral delivery systems and targeted delivery system have been extensively studied. The continued effort in this area will lead us to develop gene medicine as "gene as a drug'' in the near future.
引用
收藏
页码:1 / 15
页数:15
相关论文
共 156 条
[1]
Inhibition of angiogenesis and vascular tumor growth by interferon-producing cells -: A gene therapy approach [J].
Albini, A ;
Marchisone, C ;
Del Grosso, F ;
Benelli, R ;
Masiello, L ;
Tacchetti, C ;
Bono, M ;
Ferrantini, M ;
Rozera, C ;
Truini, M ;
Belardelli, F ;
Santi, L ;
Noonan, DM .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (04) :1381-1393
[2]
Gene transfer and models of gene therapy for the myocardium [J].
Alexander, MY ;
Webster, KA ;
McDonald, PH ;
Prentice, HM .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1999, 26 (09) :661-668
[3]
Specific cytotoxic T lymphocytes in gene therapy [J].
Altenschmidt, U ;
Moritz, D ;
Groner, B .
JOURNAL OF MOLECULAR MEDICINE-JMM, 1997, 75 (04) :259-266
[4]
Anderson WF, 1998, NATURE, V392, P25
[5]
Gene therapy - The best of times, the worst of times [J].
Anderson, WF .
SCIENCE, 2000, 288 (5466) :627-+
[6]
SEPTEMBER 14, 1990 - THE BEGINNING [J].
ANDERSON, WF .
HUMAN GENE THERAPY, 1990, 1 (04) :371-372
[7]
Biological barriers to cellular delivery of lipid-based DNA carriers [J].
Bally, MB ;
Harvie, P ;
Wong, FMP ;
Kong, S ;
Wasan, EK ;
Reimer, DL .
ADVANCED DRUG DELIVERY REVIEWS, 1999, 38 (03) :291-315
[8]
Cationic lipids are essential for gene delivery mediated by intravenous administration of lipoplexes [J].
Barron, LG ;
Uyechi, LS ;
Szoka, FC .
GENE THERAPY, 1999, 6 (06) :1179-1183
[9]
Targetability of novel immunoliposomes prepared by a new antibody conjugation technique [J].
Bendas, G ;
Krause, A ;
Bakowsky, U ;
Vogel, J ;
Rothe, U .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 181 (01) :79-93
[10]
SUBMICRON EMULSIONS AS COLLOIDAL DRUG CARRIERS FOR INTRAVENOUS ADMINISTRATION - COMPREHENSIVE PHYSICOCHEMICAL CHARACTERIZATION [J].
BENITA, S ;
LEVY, MY .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1993, 82 (11) :1069-1079